Zobrazeno 1 - 2
of 2
pro vyhledávání: '"V. A. KLUGE"'
Autor:
V. A. Kluge, T. Yu. Semiglazova, P. V. Krivorotko, E. V. Melnikova, V. V. Semiglazov, K. O. Kondrateva, S. G. Nazarova, M. A. Tynkasova, B. S. Kasparov, B. M. Adhamov, R. S. Pesotsky, K. Yu. Zernov, D. V. Kovlen, V. F. Semiglazov, A. V. Belyaev
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 196-204 (2020)
The relevance: more than 60% of cases are due to early breast cancer (EBC). Priority is the treatment of patients with early breast cancer, provided that the maximum quality of life (QL) is maintained. During or after complex treatment, more than hal
Externí odkaz:
https://doaj.org/article/2c73d6d8641d4a13980fc5b24e399049
Autor:
T. Y. SEMIGLAZOVA, A. S. ZHABINA, А. V. BELYAEVA, V. A. KLUGE, K. V. USOVA, D. H. LATIPOVA, G. M. TELETAEVA, A. V. NOVIK, A. I. SEMENOVA, S. A. PROTSENKO
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 56-65 (2016)
Conversion of the incurable disease in the chronic form and improvement of the life quality parameters on the background of appearance of new drugs is of specific importance for patients with NSCLC with activating mutations. “ESMO thinks that treat
Externí odkaz:
https://doaj.org/article/7ac0b7e66bad4bcaa3c872a3ba8a7d62